These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2196080)

  • 1. Efficacy of cyclosporin A in psoriasis: a summary of the United States' experience.
    Fradin MS; Ellis CN; Voorhees JJ
    Br J Dermatol; 1990 Jun; 122 Suppl 36():21-5. PubMed ID: 2196080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral cyclosporin A in the treatment of psoriasis: an overview of studies performed in The Netherlands.
    Meinardi MM; de Rie MA; Bos JD
    Br J Dermatol; 1990 Jun; 122 Suppl 36():27-31. PubMed ID: 2196081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis.
    Maza A; Montaudié H; Sbidian E; Gallini A; Aractingi S; Aubin F; Bachelez H; Cribier B; Joly P; Jullien D; Le Maître M; Misery L; Richard MA; Ortonne JP; Paul C
    J Eur Acad Dermatol Venereol; 2011 May; 25 Suppl 2():19-27. PubMed ID: 21388455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose cyclosporin A in severe psoriasis. A double-blind study.
    Van Joost T; Bos JD; Heule F; Meinardi MM
    Br J Dermatol; 1988 Feb; 118(2):183-90. PubMed ID: 3280000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of side-effects of medium- and low-dose cyclosporin maintenance therapy in psoriasis.
    de Rie MA; Meinardi MM; Bos JD
    Br J Dermatol; 1990 Sep; 123(3):347-53. PubMed ID: 2206973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A: preliminary results in the treatment of psoriasis.
    Bonifati C; Clerico R; Potenza CM; Carlesimo M
    Acta Derm Venereol Suppl (Stockh); 1989; 146():151-4. PubMed ID: 2532844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of low-dose cyclosporin A in psoriasis: results of dose-finding studies.
    Timonen P; Friend D; Abeywickrama K; Laburte C; von Graffenried B; Feutren G
    Br J Dermatol; 1990 Jun; 122 Suppl 36():33-9. PubMed ID: 2196082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis.
    Laburte C; Grossman R; Abi-Rached J; Abeywickrama KH; Dubertret L
    Br J Dermatol; 1994 Mar; 130(3):366-75. PubMed ID: 8148280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term use of cyclosporin A in severe psoriasis.
    Van Joost T; Heule F; Stolz E; Beukers R
    Br J Dermatol; 1986 May; 114(5):615-20. PubMed ID: 3718852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cyclosporin A (CyA) in psoriasis: an overview of dose/response, indications, contraindications and side-effects.
    Zachariae H; Steen Olsen T
    Clin Nephrol; 1995 Mar; 43(3):154-8. PubMed ID: 7774070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal function after long-term low-dose cyclosporin for psoriasis.
    Powles AV; Carmichael D; Hulme B; Thomas E; McFadden J; Baker B; Valdimarsson H; Fry L
    Br J Dermatol; 1990 May; 122(5):665-9. PubMed ID: 2112945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cyclosporin in psoriasis.
    Bos JD; Meinardi MM; van Joost T; Heule F; Powles AV; Fry L
    Lancet; 1989 Dec 23-30; 2(8678-8679):1500-2. PubMed ID: 2574777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of cyclosporin A level for efficacy or renal dysfunction in psoriasis.
    Feutren G; Friend D; Timonen P; Barnes A; Laburte C
    Br J Dermatol; 1990 Jun; 122 Suppl 36():85-93. PubMed ID: 2369572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action and rationale for cyclosporin A in psoriasis.
    Borel JF
    Br J Dermatol; 1990 Jun; 122 Suppl 36():5-12. PubMed ID: 2369569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained renal function loss in psoriasis patients after withdrawal of low-dose cyclosporin therapy.
    Korstanje MJ; Bilo HJ; Stoof TJ
    Br J Dermatol; 1992 Nov; 127(5):501-4. PubMed ID: 1467290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin in psoriasis. A long-term randomized study on 37 patients.
    Dubertret L; Perussel M; Robiola O; Feutren G
    Acta Derm Venereol Suppl (Stockh); 1989; 146():136. PubMed ID: 2692368
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trial with cyclosporin A.
    Cimitan A; Fantini F; Giannetti A
    Acta Derm Venereol Suppl (Stockh); 1989; 146():159-62; discussion 162-3. PubMed ID: 2692370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A in atopic dermatitis.
    Ross JS; Camp RD
    Br J Dermatol; 1990 Jun; 122 Suppl 36():41-5. PubMed ID: 2196083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four years of experience with cyclosporin A for psoriasis.
    Powles AV; Baker BS; Valdimarsson H; Hulme B; Fry L
    Br J Dermatol; 1990 Jun; 122 Suppl 36():13-9. PubMed ID: 2369568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of cyclosporin treatment of severe, chronic psoriasis vulgaris].
    Engst R; Huber J
    Hautarzt; 1989 Aug; 40(8):486-9. PubMed ID: 2676910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.